PL2838903T3 - Sposoby i kompozycje do leczenia zakażeń wirusowych - Google Patents

Sposoby i kompozycje do leczenia zakażeń wirusowych

Info

Publication number
PL2838903T3
PL2838903T3 PL13777543T PL13777543T PL2838903T3 PL 2838903 T3 PL2838903 T3 PL 2838903T3 PL 13777543 T PL13777543 T PL 13777543T PL 13777543 T PL13777543 T PL 13777543T PL 2838903 T3 PL2838903 T3 PL 2838903T3
Authority
PL
Poland
Prior art keywords
compositions
methods
viral infections
treating viral
treating
Prior art date
Application number
PL13777543T
Other languages
English (en)
Inventor
Richard K. Haynes
Dana G. WOLF
Original Assignee
The Hong Kong University Of Science And Technology
Hadasit Medical Research Services And Development Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Hong Kong University Of Science And Technology, Hadasit Medical Research Services And Development Ltd. filed Critical The Hong Kong University Of Science And Technology
Publication of PL2838903T3 publication Critical patent/PL2838903T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/18—Bridged systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
PL13777543T 2012-04-18 2013-04-17 Sposoby i kompozycje do leczenia zakażeń wirusowych PL2838903T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261625701P 2012-04-18 2012-04-18
EP13777543.3A EP2838903B1 (en) 2012-04-18 2013-04-17 Methods and compositions for treating viral infections
PCT/IL2013/050335 WO2013157005A1 (en) 2012-04-18 2013-04-17 Methods and compositions for treating viral infections

Publications (1)

Publication Number Publication Date
PL2838903T3 true PL2838903T3 (pl) 2018-04-30

Family

ID=49383023

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13777543T PL2838903T3 (pl) 2012-04-18 2013-04-17 Sposoby i kompozycje do leczenia zakażeń wirusowych

Country Status (11)

Country Link
US (2) US9616067B2 (pl)
EP (1) EP2838903B1 (pl)
JP (1) JP6335877B2 (pl)
CN (1) CN104379587A (pl)
AU (1) AU2013250714A1 (pl)
BR (1) BR112014026158A2 (pl)
DK (1) DK2838903T3 (pl)
ES (1) ES2650962T3 (pl)
PL (1) PL2838903T3 (pl)
PT (1) PT2838903T (pl)
WO (1) WO2013157005A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3768273A4 (en) 2018-03-22 2022-02-16 Hadasit Medical Research Services and Development Ltd. METHODS AND SYNERGIC COMPOSITIONS FOR THE TREATMENT OF VIRUS INFECTION
GB201805665D0 (en) * 2018-04-05 2018-05-23 Univ Nottingham Antiviral Compounds And Methods

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920147A (en) 1989-03-28 1990-04-24 Mcchesney James D Deoxoartemisinin: new compound and composition for the treatment of malaria
CN1049435C (zh) * 1994-11-09 2000-02-16 中国科学院上海药物研究所 含苯基和杂环基的青蒿素衍生物及其制备方法
CH692321A5 (de) 1997-11-03 2002-05-15 Mepha Ag Pharmazeutisch wirksame Zusammensetzung, welche eine gegen Malariaparasiten wirksame Substanz enthält.
NZ509324A (en) 1998-07-14 2003-07-25 Bayer Ag Antiparasitic artemisinin derivatives (endoperoxides)
AU4922499A (en) 1998-07-14 2000-02-07 Hong Kong University Of Science & Technology, The Trioxane derivatives
AU2003215584A1 (en) * 2002-03-08 2003-09-22 Bayer Business Services Gmbh Antiparasitic artemisinin derivatives (endoperoxides)
US7842719B2 (en) 2002-10-31 2010-11-30 Kemin Foods, L.C. Use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis C, bovine viral diarrhea and classical swine fever virus
ES2353384T3 (es) 2003-02-12 2011-03-01 Georgetown University Uso de artemisinina para tratar tumores inducidos por virus oncogénicos y para tratar infecciones víricas.
DE102004027871B3 (de) 2004-06-08 2006-03-16 Lanxess Deutschland Gmbh Verfahren zur Herstellung von 10α-[4'-(S,S-Dioxothiomorpholin-1'-yl)]-10-desoxo-10-dihydroartemisinin
WO2007040469A2 (en) 2005-09-15 2007-04-12 Kosak Ken M Chloroquine coupled compositions and methods for their synthesis
US20080161324A1 (en) 2006-09-14 2008-07-03 Johansen Lisa M Compositions and methods for treatment of viral diseases
US8883765B2 (en) 2009-12-08 2014-11-11 The John Hopkins University Anti-cytomegalovirus activity of artemisinin-derived dimers

Also Published As

Publication number Publication date
ES2650962T3 (es) 2018-01-23
US20150072979A1 (en) 2015-03-12
EP2838903A1 (en) 2015-02-25
JP2015514748A (ja) 2015-05-21
EP2838903B1 (en) 2017-09-06
PT2838903T (pt) 2017-12-13
EP2838903A4 (en) 2015-11-04
US10111884B2 (en) 2018-10-30
DK2838903T3 (en) 2017-12-11
US9616067B2 (en) 2017-04-11
CN104379587A (zh) 2015-02-25
AU2013250714A1 (en) 2014-11-27
JP6335877B2 (ja) 2018-05-30
BR112014026158A2 (pt) 2017-06-27
WO2013157005A1 (en) 2013-10-24
US20170071952A1 (en) 2017-03-16

Similar Documents

Publication Publication Date Title
IL238416A0 (en) Preparations and methods for the treatment of diseases caused by protein pathology
ZA201500921B (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diaseases
IL245778B (en) Methods and preparations for the treatment of hemophilia
ZA201405820B (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
PL2925888T3 (pl) Kompozycje i sposoby do stosowania w leczeniu nowotworów
ZA201405694B (en) Virus like particle composition
ZA201404061B (en) Compositions and methods for treating the hepatitis c virus
DK3292875T3 (en) Compositions and methods for treating diseases
IL237173A0 (en) Methods for treating hepatitis b and hepatitis d infections
IL234829A0 (en) Methods and preparations for treating inflammation
EP2869821A4 (en) COMPOSITIONS AND METHODS FOR TREATING AND INHIBITING VIRAL INFECTIONS
IL233968A (en) Compounds and preparations containing them for the treatment of fibrosis
HUE050413T2 (hu) Kompozíciók és eljárások fertõzéses megbetegedés kezelésére
ZA201503474B (en) Compositions and methods for treating bacterial infections
GB201315350D0 (en) Methods and compositions
SG11201405559TA (en) Component and method for treating viral disease
GB201315347D0 (en) Methods and compositions
ZA201501601B (en) Virus purification and formulation process
IL238602A0 (en) Preparations and methods for the treatment of ectodermal dysplasia
PT2838903T (pt) Métodos e composições para tratamento de infeções virais
EP2838526A4 (en) MATERIALS AND METHODS FOR PREVENTING AND TREATING VIRAL INFECTIONS
EP2887967A4 (en) COMPOSITIONS AND METHODS FOR TREATING HEPATOCELLULAR CANCER
SG11201402899TA (en) Methods and compositions for treating viral diseases
GB201222736D0 (en) Composition and process
EP2747765A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL DISEASES